Literature DB >> 11554170

Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.

F Vega1, L J Medeiros, C Bueso-Ramos, D Jones, R Lai, R Luthra, L V Abruzzo.   

Abstract

We report 8 cases of hepatosplenic T-cell lymphoma (HSTCL) involving bone marrow and correlate histologic findings with disease progression. Immunophenotypic analysis demonstrated mature, aberrant gamma/delta T-cell immunophenotypes. Isochromosome 7q was identified in 4 cases; 1 case showed the t(7;14)(q34;q13). Seven of 7 cases tested had monoclonal TCR gamma gene rearrangements. The initial diagnostic bone marrow biopsy specimens were hypercellular with a frequently subtle, predominantly sinusoidal infiltrate of atypical small to medium-sized lymphoid cells. In all cases, aspirate smears at diagnosis and in subsequent specimens contained malignant cells that resembled blasts, some with fine cytoplasmic granules. With progression, the pattern of HSTCL in bone marrow biopsy specimens became increasingly interstitial, and the neoplastic cells became larger. In aspirate smears, the proportion of blasts increased. Seven patients died; 1 was lost to follow-up. Autopsy performed on 1 patient demonstrated malignant cells within vascular channels in all organs sampled, with relatively little tumor formation, resembling intravascular lymphoma at these sites. HSTCL often can be recognized in bone marrow by its unique combination of a sinusoidal pattern in core biopsy specimens and blastic cytology in aspirate smears.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554170     DOI: 10.1309/BM40-YM6J-9T3X-MH8H

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology.

Authors:  Sanam Loghavi; Sa A Wang; L Jeffrey Medeiros; Jeffrey L Jorgensen; Xin Li; Zijun Y Xu-Monette; Roberto N Miranda; Ken H Young
Journal:  Leuk Lymphoma       Date:  2016-04-22

2.  Hepatosplenic T cell lymphoma: a rare case report.

Authors:  Monalisa Hui; Shantveer G Uppin; Tara Roshni Paul; N Beerappa
Journal:  Indian J Hematol Blood Transfus       Date:  2012-12-18       Impact factor: 0.900

3.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

Review 4.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

Review 5.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

6.  Hepatosplenic T-cell lymphoma: a rare cause of hepatosplenomegaly.

Authors:  Ana Cristina Lladó; Ana Luisa Tomé; Maria Henrique; Pedro Farinha
Journal:  BMJ Case Rep       Date:  2014-07-10

7.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

8.  Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.

Authors:  Liuyan Jiang; Andrea D Abati; Wyndham Wilson; Maryalice Stetler-Stevenson; Constance Yuan
Journal:  Int J Clin Exp Pathol       Date:  2009-10-15

9.  Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.

Authors:  Farhad Ravandi; Ahmed Aribi; Susan O'Brien; Stefan Faderl; Dan Jones; Alessandra Ferrajoli; Xuelin Huang; Sergernne York; Sherry Pierce; William Wierda; Dimitrios Kontoyiannis; Srdan Verstovsek; Barbara Pro; Luis Fayad; Michael Keating; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

Review 10.  [Lymphomas and lymphatic leukemias in the bone marrow].

Authors:  P Adam; L Quintanilla-Fend; F Fend
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.